Amarin reported $91.05 in PE Price to Earnings for its fiscal quarter ending in June of 2023.





Pe Change Date
AbbVie USD 110.26 91.85 Sep/2025
Amarin USD 91.05 88.3 Jun/2023
AstraZeneca USD 21.49 1.46 Sep/2025
GlaxoSmithKline GBP 11.44 6.82 Sep/2025
Halozyme Therapeutics USD 15.46 3.56 Sep/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Neurocrine Biosciences USD 33.27 9.34 Sep/2025
Novartis USD 15.74 0.15 Sep/2025